HER2 Amplification Ratios by Fluorescence In Situ Hybridization and Correlation with Immunohistochemistry in a Cohort of 6556 Breast Cancer Tissues

References

Page 1

	Year	Citations
Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/<i>neu</i>Oncogene Dennis J. Slamon, Gary M. Clark, Steven Wong, Science	1987	11.6K
Studies of the HER-2/ <i>neu</i> Proto-Oncogene in Human Breast and Ovarian Cancer Dennis J. Slamon, William Godolphin, Lovell A. Jones, Science	1989	6.8K
Multinational Study of the Efficacy and Safety of Humanized Anti-HER2 Monoclonal Antibody in Women Who Have HER2-Overexpressing Metastatic Breast Cancer That Has Progressed After Chemotherapy for Metastatic Disease Melody Cobleigh, Charles L. Vogel, Debu Tripathy, Journal of Clinical Oncology	1999	2.8K
Phase II study of receptor-enhanced chemosensitivity using recombinant humanized anti-p185HER2/neu monoclonal antibody plus cisplatin in patients with HER2/neu-overexpressing metastatic breast cancer refractory to chemotherapy treatment. Mark D. Pegram, A. Lipton, Daniel F. Hayes, Journal of Clinical Oncology	1998	1.1K
Recombinant humanized anti-HER2 antibody (Herceptin) enhances the antitumor activity of paclitaxel and doxorubicin against HER2/neu overexpressing human breast cancer xenografts. José Baselga, Larry Norton, Joan Albanell, PubMed Her2-overexpressing Cancer CellsAntitumor ActivityBreast OncologyMedicinePharmacology	1998	1K
HER-2/neu gene amplification characterized by fluorescence in situ hybridization: poor prognosis in node-negative breast carcinomas. Michael F. Press, Leslie Bernstein, P. Thomas, Journal of Clinical Oncology	1997	810
Assessment of Methods for Tissue-Based Detection of the HER-2/neu Alteration in Human Breast Cancer: A Direct Comparison of Fluorescence In Situ Hybridization and Immunohistochemistry Giovanni M. Pauletti, Suganda Dandekar, Hong-Mei Rong, Journal of Clinical Oncology	2000	684
erbB-2 and Response to Doxorubicin in Patients With Axillary Lymph Node-Positive, Hormone Receptor- Negative Breast Cancer Soonmyung Paik, John Bryant, Chanheun Park, JNCI Journal of the National Cancer Institute	1998	653
Pathologic findings from the National Surgical Adjuvant Breast and Bowel Project: prognostic significance of erbB-2 protein overexpression in primary breast cancer. Soonmyoung Paik, Rachel B. Hazan, Edwin R. Fisher, Journal of Clinical Oncology Breast OncologyPathologyPrognostic SignificanceErbb-2 Protein OverexpressionBowel Project	1990	595
Detection and quantitation of HER-2/neu gene amplification in human breast cancer archival material using fluorescence in situ hybridization. Giovanni M. Pauletti, William Godolphin, M F Press, PubMed	1996	560

Page 1